Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising improvements across numerous healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, more responsible alternative for therapeutic use, signi